Asset Details
Do you wish to reserve the book?
Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues
Do you wish to request the book?
Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues
2011
Overview
Background
Recently, those substances deriving from the active ingredient of the Khat plant, cathinone, have been rising in popularity. Indeed, 4-methylmethcathinone (mephedrone; ‘meow meow’ and others) has been seen by some as a cheaper alternative to other classified recreational drugs.
Aims
We aimed here at providing a state-of-the-art review on mephedrone history and prevalence of misuse, chemistry, pharmacology, legal status, product market appearance, clinical/management and related fatalities.
Methods
Because of the limited evidence, some of the information here presented has been obtained from user reports/drug user-orientated web sites. The most common routes for mephedrone recreational use include insufflation and oral ingestion. It elicits stimulant and empathogenic effects similar to amphetamine, methylamphetamine, cocaine and MDMA. Due to its sympathomimetic actions, mephedrone may be associated with a number of both physical and psychopathological side effects. Recent preliminary analysis of recent UK data carried out in 48 related cases have provided positive results for the presence of mephedrone at postmortem.
Discussion and Conclusions
Within the UK, diffusion of mephedrone may have been associated with an unprecedented combination of a particularly aggressive online marketing policy and a decreasing availability/purity of both ecstasy and cocaine. Mephedrone has been recently classified in both the UK and in a number of other countries as a measure to control its availability. Following this, a few other research psychoactives have recently entered the online market as yet unregulated substances that may substitute for mephedrone. Only international collaborative efforts may be able to tackle the phenomenon of the regular offer of novel psychoactive drugs.
Publisher
Springer Berlin Heidelberg,Springer,Springer Nature B.V
Subject
/ Adult and adolescent clinical studies
/ Animals
/ Biological and medical sciences
/ Biomedical and Life Sciences
/ Cocaine
/ Complications and side effects
/ Designer Drugs - adverse effects
/ Designer Drugs - pharmacology
/ Designer Drugs - therapeutic use
/ Drug use
/ Ecstasy
/ Humans
/ MDMA
/ Methamphetamine - adverse effects
/ Methamphetamine - analogs & derivatives
/ Methamphetamine - pharmacology
/ Methamphetamine - therapeutic use
/ Pharmacology. Drug treatments
/ Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer
/ Psychology. Psychoanalysis. Psychiatry
/ Qat
/ Review
/ Substance-Related Disorders - drug therapy
